Evidence map›Paper›PMID 30254054›Full record

ArticleScience signaling2018

Arrestins and G proteins in cellular signaling: The coin has two sides.

Vsevolod V Gurevich, Eugenia V Gurevich

Abstract readComment
In one paragraph

Article in Science signaling, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed.

  1. Review
  2. Article
  3. Arrestins: A Small Family of Multi-Functional Proteins.International journal of molecular sciences · 2024
    Review
  4. LPAInternational journal of molecular sciences · 2024
    Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Many faces of the GPCR-arrestin interaction.Archives of pharmacal research · 2020
    Review
  14. Review
  15. Phosphorylation barcode-dependent signal bias of the dopamine D1 receptor.Proceedings of the National Academy of Sciences of the United States of America · 2020
    Article
  16. Cannabinoid Receptor 2 (CBACS pharmacology & translational science · 2019
    Article
  17. Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Vsevolod V GurevichDepartment of Pharmacology, Vanderbilt University, Nashville, TN 37232, USA. vsevolod.gurevich@vanderbilt.edu.ORCID 0000-0002-3950-5351
Eugenia V GurevichDepartment of Pharmacology, Vanderbilt University, Nashville, TN 37232, USA.ORCID 0000-0002-0563-8295

Funding

STRUCTURE/FUNCTION STUDIES OF VISUAL ARRESTINR01EY011500 · NEI · VANDERBILT UNIVERSITY · PI T M Iverson · 1997 to 2026
$12.3M
Targeted Engineering of Designer Arrestins to Regulate Cell SignalingR35GM122491 · NIGMS · VANDERBILT UNIVERSITY · PI GUREVICH, VSEVOLOD V. · 2017 to 2021
$2.6M
Signaling regulation in the striatum in Parkinson's diseaseR01NS065868 · NINDS · VANDERBILT UNIVERSITY · PI GUREVICH, EUGENIA V · 2009 to 2013
$1.7M
The role of receptor desensitization machinery in psychostimulant addictionR21DA030103 · NIDA · VANDERBILT UNIVERSITY · PI GUREVICH, EUGENIA V · 2011 to 2012
$390k
NEI NIH HHS R01 EY011500NIDA NIH HHS R21 DA030103NIGMS NIH HHS R35 GM122491NINDS NIH HHS R01 NS065868
6 · The paper itself

Abstract

Several studies have suggested that arrestin-mediated signaling by GPCRs requires G protein activation; however, in this issue of

Indexed as

ArrestinsCRISPR-Cas Systemsbeta-ArrestinsPhosphorylationRNA, Small InterferingArrestinsbeta-ArrestinsRNA, Small Interfering

Identifiers

PMID30254054
PMCPMC6390952

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.